Symposium 2024 day 4 centered around on OGM’s potential to serve as a genomic integrity tool for cell and gene therapy applications, supporting the development of in vivo gene therapies. Six Panelists will cover OGM’s ability to screen cell lines for genomic instability and off-target events associated with genome editing.
Quality Control for Cell Genomic Integrity – Teach Me In 10 with Dr. Sam Dougaparsad of Bionano
Sam Dougaparsad, PhD – Bionano Symposium 2024
Samantha Maragh, PhD – Bionano Symposium 2024
Alex Hastie, PhD – Bionano Symposium 2024
Andy Pang, PhD – Bionano Symposium 2024
Owen Pearce – Bionano Symposium 2024
Thanks for getting in touch!
We typically respond within 24 hours. In the meantime, feel free to checkout our frequently asked questions.